APO Research
Talk to an analyst

APO RESEARCH · REPORT

Injectable Suspension Budesonide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Injectable Suspension Budesonide Industry Growth and Trends Forecast to 2032

19 December 2025109 pages

Choose your research edition.

Industry ResearchInjectable Suspension Budesonide Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Injectable Suspension Budesonide Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Injectable Suspension Budesonide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injectable Suspension Budesonide Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Injectable Suspension Budesonide Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Injectable Suspension Budesonide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Injectable Suspension Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Injectable Suspension Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Injectable Suspension Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Injectable Suspension Budesonide include Teva, Shanghai Sine Promod, Sandoz, Mylan, Lunan Better Pharma, Synmosa Biopharma, AstraZeneca, Salix and Orion Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Injectable Suspension Budesonide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Injectable Suspension Budesonide market size, estimates, and forecasts are presented in terms of sales volume (K L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Injectable Suspension Budesonide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Injectable Suspension Budesonide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Injectable Suspension Budesonide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Injectable Suspension Budesonide Market by Company

Teva

Shanghai Sine Promod

Sandoz

Mylan

Lunan Better Pharma

Synmosa Biopharma

AstraZeneca

Salix

Orion Corporation

Cosmo Pharmaceuticals

Cipla

Chiesi Farmaceutici

Injectable Suspension Budesonide Segment by Type

0.5mg

1mg

Injectable Suspension Budesonide Segment by Application

Inflammatory Bowel Disease Treatment

Respiratory Disease Treatment

Nose Disease Treatment

Other

Injectable Suspension Budesonide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Suspension Budesonide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable Suspension Budesonide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Suspension Budesonide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Injectable Suspension Budesonide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Injectable Suspension Budesonide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.5mg Table 2. Major Company of 1mg Table 3. Global Injectable Suspension Budesonide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Injectable Suspension Budesonide Sales by Type (2021-2026) & (K L) Table 5. Global Injectable Suspension Budesonide Sales Market Share in Volume by Type (2021-2026) Table 6. Global Injectable Suspension Budesonide Sales by Type (2021-2026) & (US$ Million) Table 7. Global Injectable Suspension Budesonide Sales Market Share in Value by Type (2021-2026) Table 8. Global Injectable Suspension Budesonide Price by Type (2021-2026) & (US$/L) Table 9. Global Injectable Suspension Budesonide Sales by Type (2027-2032) & (K L) Table 10. Global Injectable Suspension Budesonide Sales Market Share in Volume by Type (2027-2032) Table 11. Global Injectable Suspension Budesonide Sales by Type (2027-2032) & (US$ Million) Table 12. Global Injectable Suspension Budesonide Sales Market Share in Value by Type (2027-2032) Table 13. Global Injectable Suspension Budesonide Price by Type (2027-2032) & (US$/L) Table 14. North America Injectable Suspension Budesonide Sales by Type (2021-2026) & (K L) Table 15. North America Injectable Suspension Budesonide Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Injectable Suspension Budesonide Sales by Type (2021-2026) & (K L) Table 17. Europe Injectable Suspension Budesonide Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Injectable Suspension Budesonide Sales by Type (2021-2026) & (K L) Table 19. Asia-Pacific Injectable Suspension Budesonide Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Injectable Suspension Budesonide Sales by Type (2021-2026) & (K L) Table 21. Latin America Injectable Suspension Budesonide Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Injectable Suspension Budesonide Sales by Type (2021-2026) & (K L) Table 23. Middle East and Africa Injectable Suspension Budesonide Sales by Type (2021-2026) & (US$ Million) Table 24. Injectable Suspension Budesonide Industry Trends Table 25. Injectable Suspension Budesonide Industry Drivers Table 26. Injectable Suspension Budesonide Industry Opportunities and Challenges Table 27. Injectable Suspension Budesonide Industry Restraints Table 28. Global Injectable Suspension Budesonide Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Injectable Suspension Budesonide Revenue Market Share by Company (2021-2026) Table 30. Global Injectable Suspension Budesonide Sales by Company (2021-2026) & (K L) Table 31. Global Injectable Suspension Budesonide Sales Share by Company (2021-2026) Table 32. Global Injectable Suspension Budesonide Market Price by Company (2021-2026) & (US$/L) Table 33. Global Injectable Suspension Budesonide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Injectable Suspension Budesonide Major Company Production Sites and Headquarters Table 35. Global Injectable Suspension Budesonide Company, Product Type & Application Table 36. Global Injectable Suspension Budesonide Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Injectable Suspension Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Injectable Suspension Budesonide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Injectable Suspension Budesonide Sales by Region (2021-2026) & (K L) Table 41. Global Injectable Suspension Budesonide Sales Market Share in Volume by Region (2021-2026) Table 42. Global Injectable Suspension Budesonide Sales by Region (2021-2026) & (US$ Million) Table 43. Global Injectable Suspension Budesonide Sales Market Share in Value by Region (2021-2026) Table 44. Global Injectable Suspension Budesonide Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 45. Global Injectable Suspension Budesonide Sales by Region (2027-2032) & (K L) Table 46. Global Injectable Suspension Budesonide Sales Market Share in Volume by Region (2027-2032) Table 47. Global Injectable Suspension Budesonide Sales by Region (2027-2032) & (US$ Million) Table 48. Global Injectable Suspension Budesonide Sales Market Share in Value by Region (2027-2032) Table 49. Global Injectable Suspension Budesonide Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2027-2032) Table 50. Global Injectable Suspension Budesonide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Injectable Suspension Budesonide Sales by Application (2021-2026) & (K L) Table 52. Global Injectable Suspension Budesonide Sales Market Share in Volume by Application (2021-2026) Table 53. Global Injectable Suspension Budesonide Sales by Application (2021-2026) & (US$ Million) Table 54. Global Injectable Suspension Budesonide Sales Market Share in Value by Application (2021-2026) Table 55. Global Injectable Suspension Budesonide Price by Application (2021-2026) & (US$/L) Table 56. Global Injectable Suspension Budesonide Sales by Application (2027-2032) & (K L) Table 57. Global Injectable Suspension Budesonide Sales Market Share in Volume by Application (2027-2032) Table 58. Global Injectable Suspension Budesonide Sales by Application (2027-2032) & (US$ Million) Table 59. Global Injectable Suspension Budesonide Sales Market Share in Value by Application (2027-2032) Table 60. Global Injectable Suspension Budesonide Price by Application (2027-2032) & (US$/L) Table 61. North America Injectable Suspension Budesonide Sales by Application (2021-2026) & (K L) Table 62. North America Injectable Suspension Budesonide Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Injectable Suspension Budesonide Sales by Application (2021-2026) & (K L) Table 64. Europe Injectable Suspension Budesonide Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Injectable Suspension Budesonide Sales by Application (2021-2026) & (K L) Table 66. Asia-Pacific Injectable Suspension Budesonide Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Injectable Suspension Budesonide Sales by Application (2021-2026) & (K L) Table 68. Latin America Injectable Suspension Budesonide Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Injectable Suspension Budesonide Sales by Application (2021-2026) & (K L) Table 70. Middle East and Africa Injectable Suspension Budesonide Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 74. Teva Injectable Suspension Budesonide Product Portfolio Table 75. Teva Recent Development Table 76. Shanghai Sine Promod Company Information Table 77. Shanghai Sine Promod Business Overview Table 78. Shanghai Sine Promod Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 79. Shanghai Sine Promod Injectable Suspension Budesonide Product Portfolio Table 80. Shanghai Sine Promod Recent Development Table 81. Sandoz Company Information Table 82. Sandoz Business Overview Table 83. Sandoz Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 84. Sandoz Injectable Suspension Budesonide Product Portfolio Table 85. Sandoz Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 89. Mylan Injectable Suspension Budesonide Product Portfolio Table 90. Mylan Recent Development Table 91. Lunan Better Pharma Company Information Table 92. Lunan Better Pharma Business Overview Table 93. Lunan Better Pharma Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 94. Lunan Better Pharma Injectable Suspension Budesonide Product Portfolio Table 95. Lunan Better Pharma Recent Development Table 96. Synmosa Biopharma Company Information Table 97. Synmosa Biopharma Business Overview Table 98. Synmosa Biopharma Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 99. Synmosa Biopharma Injectable Suspension Budesonide Product Portfolio Table 100. Synmosa Biopharma Recent Development Table 101. AstraZeneca Company Information Table 102. AstraZeneca Business Overview Table 103. AstraZeneca Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 104. AstraZeneca Injectable Suspension Budesonide Product Portfolio Table 105. AstraZeneca Recent Development Table 106. Salix Company Information Table 107. Salix Business Overview Table 108. Salix Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 109. Salix Injectable Suspension Budesonide Product Portfolio Table 110. Salix Recent Development Table 111. Orion Corporation Company Information Table 112. Orion Corporation Business Overview Table 113. Orion Corporation Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 114. Orion Corporation Injectable Suspension Budesonide Product Portfolio Table 115. Orion Corporation Recent Development Table 116. Cosmo Pharmaceuticals Company Information Table 117. Cosmo Pharmaceuticals Business Overview Table 118. Cosmo Pharmaceuticals Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 119. Cosmo Pharmaceuticals Injectable Suspension Budesonide Product Portfolio Table 120. Cosmo Pharmaceuticals Recent Development Table 121. Cipla Company Information Table 122. Cipla Business Overview Table 123. Cipla Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 124. Cipla Injectable Suspension Budesonide Product Portfolio Table 125. Cipla Recent Development Table 126. Chiesi Farmaceutici Company Information Table 127. Chiesi Farmaceutici Business Overview Table 128. Chiesi Farmaceutici Injectable Suspension Budesonide Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 129. Chiesi Farmaceutici Injectable Suspension Budesonide Product Portfolio Table 130. Chiesi Farmaceutici Recent Development Table 131. North America Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 132. North America Injectable Suspension Budesonide Sales by Country (2021-2026) & (K L) Table 133. North America Injectable Suspension Budesonide Sales Market Share by Country (2021-2026) Table 134. North America Injectable Suspension Budesonide Sales Forecast by Country (2027-2032) & (K L) Table 135. North America Injectable Suspension Budesonide Sales Market Share Forecast by Country (2027-2032) Table 136. North America Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Injectable Suspension Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Injectable Suspension Budesonide Market Share by Country (2021-2026) Table 139. North America Injectable Suspension Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Injectable Suspension Budesonide Market Share Forecast by Country (2027-2032) Table 141. Europe Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 142. Europe Injectable Suspension Budesonide Sales by Country (2021-2026) & (K L) Table 143. Europe Injectable Suspension Budesonide Sales Market Share by Country (2021-2026) Table 144. Europe Injectable Suspension Budesonide Sales Forecast by Country (2027-2032) & (K L) Table 145. Europe Injectable Suspension Budesonide Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Injectable Suspension Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Injectable Suspension Budesonide Market Share by Country (2021-2026) Table 149. Europe Injectable Suspension Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Injectable Suspension Budesonide Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Injectable Suspension Budesonide Sales by Country (2021-2026) & (K L) Table 153. Asia-Pacific Injectable Suspension Budesonide Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Injectable Suspension Budesonide Sales Forecast by Country (2027-2032) & (K L) Table 155. Asia-Pacific Injectable Suspension Budesonide Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Injectable Suspension Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Injectable Suspension Budesonide Market Share by Country (2021-2026) Table 159. Asia-Pacific Injectable Suspension Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Injectable Suspension Budesonide Market Share Forecast by Country (2027-2032) Table 161. Latin America Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 162. Latin America Injectable Suspension Budesonide Sales by Country (2021-2026) & (K L) Table 163. Latin America Injectable Suspension Budesonide Sales Market Share by Country (2021-2026) Table 164. Latin America Injectable Suspension Budesonide Sales Forecast by Country (2027-2032) & (K L) Table 165. Latin America Injectable Suspension Budesonide Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Injectable Suspension Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Injectable Suspension Budesonide Market Share by Country (2021-2026) Table 169. Latin America Injectable Suspension Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Injectable Suspension Budesonide Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Injectable Suspension Budesonide Sales by Country (2021-2026) & (K L) Table 173. Middle East and Africa Injectable Suspension Budesonide Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Injectable Suspension Budesonide Sales Forecast by Country (2027-2032) & (K L) Table 175. Middle East and Africa Injectable Suspension Budesonide Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Injectable Suspension Budesonide Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Injectable Suspension Budesonide Market Share by Country (2021-2026) Table 179. Middle East and Africa Injectable Suspension Budesonide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Injectable Suspension Budesonide Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Injectable Suspension Budesonide Distributors List Table 184. Injectable Suspension Budesonide Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Injectable Suspension Budesonide Image Figure 2. Global Injectable Suspension Budesonide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injectable Suspension Budesonide Market Size (2021-2032) & (US$ Million) Figure 4. Global Injectable Suspension Budesonide Sales (2021-2032) & (K L) Figure 5. 0.5mg Image Figure 6. Global 0.5mg Sales YoY Growth (2021-2032) & (K L) Figure 7. 1mg Image Figure 8. Global 1mg Sales YoY Growth (2021-2032) & (K L) Figure 9. Global Injectable Suspension Budesonide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Injectable Suspension Budesonide Market Share by Type 2025 VS 2032 Figure 11. North America Injectable Suspension Budesonide Sales Market Share in Volume by Type in 2025 Figure 12. North America Injectable Suspension Budesonide Sales Market Share in Value by Type in 2025 Figure 13. Europe Injectable Suspension Budesonide Sales Market Share in Volume by Type in 2025 Figure 14. Europe Injectable Suspension Budesonide Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Injectable Suspension Budesonide Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Injectable Suspension Budesonide Sales Market Share in Value by Type in 2025 Figure 17. Latin America Injectable Suspension Budesonide Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Injectable Suspension Budesonide Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Injectable Suspension Budesonide Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Injectable Suspension Budesonide Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Injectable Suspension Budesonide Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Inflammatory Bowel Disease Treatment Image Figure 24. Global Inflammatory Bowel Disease Treatment Sales YoY Growth (2021-2032) & (K L) Figure 25. Respiratory Disease Treatment Image Figure 26. Global Respiratory Disease Treatment Sales YoY Growth (2021-2032) & (K L) Figure 27. Nose Disease Treatment Image Figure 28. Global Nose Disease Treatment Sales YoY Growth (2021-2032) & (K L) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K L) Figure 31. Global Injectable Suspension Budesonide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Injectable Suspension Budesonide Market Share by Application 2025 VS 2032 Figure 33. North America Injectable Suspension Budesonide Sales Market Share in Volume by Application in 2025 Figure 34. North America Injectable Suspension Budesonide Sales Market Share in Value by Application in 2025 Figure 35. Europe Injectable Suspension Budesonide Sales Market Share in Volume by Application in 2025 Figure 36. Europe Injectable Suspension Budesonide Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Injectable Suspension Budesonide Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Injectable Suspension Budesonide Sales Market Share in Value by Application in 2025 Figure 39. Latin America Injectable Suspension Budesonide Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Injectable Suspension Budesonide Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Injectable Suspension Budesonide Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Injectable Suspension Budesonide Sales Market Share in Value by Application in 2025 Figure 43. North America Injectable Suspension Budesonide Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 44. North America Injectable Suspension Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Injectable Suspension Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Injectable Suspension Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Injectable Suspension Budesonide Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 48. Europe Injectable Suspension Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Injectable Suspension Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Injectable Suspension Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Injectable Suspension Budesonide Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 52. Asia-Pacific Injectable Suspension Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Injectable Suspension Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Injectable Suspension Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Injectable Suspension Budesonide Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 56. Latin America Injectable Suspension Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Injectable Suspension Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Injectable Suspension Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Injectable Suspension Budesonide Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 60. Middle East and Africa Injectable Suspension Budesonide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Injectable Suspension Budesonide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Injectable Suspension Budesonide Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Injectable Suspension Budesonide Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Injectable Suspension Budesonide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5mg
  • 1mg
Applications
  • Inflammatory Bowel Disease Treatment
  • Respiratory Disease Treatment
  • Nose Disease Treatment
  • Other
Companies covered
  • Teva
  • Shanghai Sine Promod
  • Sandoz
  • Mylan
  • Lunan Better Pharma
  • Synmosa Biopharma
  • AstraZeneca
  • Salix
  • Orion Corporation
  • Cosmo Pharmaceuticals
  • Cipla
  • Chiesi Farmaceutici

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Injectable Suspension Budesonide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Injectable Suspension Budesonide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Injectable Suspension Budesonide Market by Type
  6. 1.3.1 0.5mg
  7. 1.3.2 1mg
  8. 1.4 Global Injectable Suspension Budesonide Market Size by Type
  9. 1.4.1 Global Injectable Suspension Budesonide Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Injectable Suspension Budesonide Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Injectable Suspension Budesonide Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Injectable Suspension Budesonide Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Injectable Suspension Budesonide Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Injectable Suspension Budesonide Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Injectable Suspension Budesonide Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Injectable Suspension Budesonide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Injectable Suspension Budesonide Industry Trends
  2. 2.2 Injectable Suspension Budesonide Industry Drivers
  3. 2.3 Injectable Suspension Budesonide Industry Opportunities and Challenges
  4. 2.4 Injectable Suspension Budesonide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Injectable Suspension Budesonide Revenue (2021-2026)
  2. 3.2 Global Top Players by Injectable Suspension Budesonide Sales (2021-2026)
  3. 3.3 Global Top Players by Injectable Suspension Budesonide Price (2021-2026)
  4. 3.4 Global Injectable Suspension Budesonide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Injectable Suspension Budesonide Major Company Production Sites & Headquarters
  6. 3.6 Global Injectable Suspension Budesonide Company, Product Type & Application
  7. 3.7 Global Injectable Suspension Budesonide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Injectable Suspension Budesonide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Injectable Suspension Budesonide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Injectable Suspension Budesonide Tier 1, Tier 2, and Tier 3
4 Injectable Suspension Budesonide Regional Status and Outlook
  1. 4.1 Global Injectable Suspension Budesonide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Injectable Suspension Budesonide Historic Market Size by Region
  3. 4.2.1 Global Injectable Suspension Budesonide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Injectable Suspension Budesonide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Injectable Suspension Budesonide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Injectable Suspension Budesonide Forecasted Market Size by Region
  7. 4.3.1 Global Injectable Suspension Budesonide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Injectable Suspension Budesonide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Injectable Suspension Budesonide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Injectable Suspension Budesonide by Application
  1. 5.1 Injectable Suspension Budesonide Market by Application
  2. 5.1.1 Inflammatory Bowel Disease Treatment
  3. 5.1.2 Respiratory Disease Treatment
  4. 5.1.3 Nose Disease Treatment
  5. 5.1.4 Other
  6. 5.2 Global Injectable Suspension Budesonide Market Size by Application
  7. 5.2.1 Global Injectable Suspension Budesonide Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Injectable Suspension Budesonide Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Injectable Suspension Budesonide Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Injectable Suspension Budesonide Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Injectable Suspension Budesonide Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Injectable Suspension Budesonide Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Injectable Suspension Budesonide Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Injectable Suspension Budesonide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Injectable Suspension Budesonide Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Shanghai Sine Promod
  8. 6.2.1 Shanghai Sine Promod Company Information
  9. 6.2.2 Shanghai Sine Promod Business Overview
  10. 6.2.3 Shanghai Sine Promod Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai Sine Promod Injectable Suspension Budesonide Product Portfolio
  12. 6.2.5 Shanghai Sine Promod Recent Developments
  13. 6.3 Sandoz
  14. 6.3.1 Sandoz Company Information
  15. 6.3.2 Sandoz Business Overview
  16. 6.3.3 Sandoz Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sandoz Injectable Suspension Budesonide Product Portfolio
  18. 6.3.5 Sandoz Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Injectable Suspension Budesonide Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Lunan Better Pharma
  26. 6.5.1 Lunan Better Pharma Company Information
  27. 6.5.2 Lunan Better Pharma Business Overview
  28. 6.5.3 Lunan Better Pharma Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lunan Better Pharma Injectable Suspension Budesonide Product Portfolio
  30. 6.5.5 Lunan Better Pharma Recent Developments
  31. 6.6 Synmosa Biopharma
  32. 6.6.1 Synmosa Biopharma Company Information
  33. 6.6.2 Synmosa Biopharma Business Overview
  34. 6.6.3 Synmosa Biopharma Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Synmosa Biopharma Injectable Suspension Budesonide Product Portfolio
  36. 6.6.5 Synmosa Biopharma Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Injectable Suspension Budesonide Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 Salix
  44. 6.8.1 Salix Company Information
  45. 6.8.2 Salix Business Overview
  46. 6.8.3 Salix Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Salix Injectable Suspension Budesonide Product Portfolio
  48. 6.8.5 Salix Recent Developments
  49. 6.9 Orion Corporation
  50. 6.9.1 Orion Corporation Company Information
  51. 6.9.2 Orion Corporation Business Overview
  52. 6.9.3 Orion Corporation Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Orion Corporation Injectable Suspension Budesonide Product Portfolio
  54. 6.9.5 Orion Corporation Recent Developments
  55. 6.10 Cosmo Pharmaceuticals
  56. 6.10.1 Cosmo Pharmaceuticals Company Information
  57. 6.10.2 Cosmo Pharmaceuticals Business Overview
  58. 6.10.3 Cosmo Pharmaceuticals Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cosmo Pharmaceuticals Injectable Suspension Budesonide Product Portfolio
  60. 6.10.5 Cosmo Pharmaceuticals Recent Developments
  61. 6.11 Cipla
  62. 6.11.1 Cipla Company Information
  63. 6.11.2 Cipla Business Overview
  64. 6.11.3 Cipla Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Cipla Injectable Suspension Budesonide Product Portfolio
  66. 6.11.5 Cipla Recent Developments
  67. 6.12 Chiesi Farmaceutici
  68. 6.12.1 Chiesi Farmaceutici Company Information
  69. 6.12.2 Chiesi Farmaceutici Business Overview
  70. 6.12.3 Chiesi Farmaceutici Injectable Suspension Budesonide Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Chiesi Farmaceutici Injectable Suspension Budesonide Product Portfolio
  72. 6.12.5 Chiesi Farmaceutici Recent Developments
7 North America by Country
  1. 7.1 North America Injectable Suspension Budesonide Sales by Country
  2. 7.1.1 North America Injectable Suspension Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Injectable Suspension Budesonide Sales by Country (2021-2026)
  4. 7.1.3 North America Injectable Suspension Budesonide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Injectable Suspension Budesonide Market Size by Country
  6. 7.2.1 North America Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Injectable Suspension Budesonide Market Size by Country (2021-2026)
  8. 7.2.3 North America Injectable Suspension Budesonide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Injectable Suspension Budesonide Sales by Country
  2. 8.1.1 Europe Injectable Suspension Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Injectable Suspension Budesonide Sales by Country (2021-2026)
  4. 8.1.3 Europe Injectable Suspension Budesonide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Injectable Suspension Budesonide Market Size by Country
  6. 8.2.1 Europe Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Injectable Suspension Budesonide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Injectable Suspension Budesonide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Injectable Suspension Budesonide Sales by Country
  2. 9.1.1 Asia-Pacific Injectable Suspension Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Injectable Suspension Budesonide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Injectable Suspension Budesonide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Injectable Suspension Budesonide Market Size by Country
  6. 9.2.1 Asia-Pacific Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Injectable Suspension Budesonide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Injectable Suspension Budesonide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Injectable Suspension Budesonide Sales by Country
  2. 10.1.1 South America Injectable Suspension Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Injectable Suspension Budesonide Sales by Country (2021-2026)
  4. 10.1.3 South America Injectable Suspension Budesonide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Injectable Suspension Budesonide Market Size by Country
  6. 10.2.1 South America Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Injectable Suspension Budesonide Market Size by Country (2021-2026)
  8. 10.2.3 South America Injectable Suspension Budesonide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Injectable Suspension Budesonide Sales by Country
  2. 11.1.1 Middle East and Africa Injectable Suspension Budesonide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Injectable Suspension Budesonide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Injectable Suspension Budesonide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Injectable Suspension Budesonide Market Size by Country
  6. 11.2.1 Middle East and Africa Injectable Suspension Budesonide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Injectable Suspension Budesonide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Injectable Suspension Budesonide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Injectable Suspension Budesonide Value Chain Analysis
  2. 12.1.1 Injectable Suspension Budesonide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Injectable Suspension Budesonide Production Mode & Process
  7. 12.2 Injectable Suspension Budesonide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Injectable Suspension Budesonide Distributors
  10. 12.2.3 Injectable Suspension Budesonide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst